"funny" things is we know more about Cosmos than endocrinology.
One other critical aspect of it when it comes to hair loss and what men are willing to undergo, is the age at which it happens. In my case, having good hair all through my 20s and then a manageable (yet aware of) hair situation through my 30s, simplified things and gave me the time and opportunity to take step back and think about it. Had it been occuring in my early 20s, I would have probably been more desperate, more risk taking and value hair more than other things. I feel like the world of hair loss is unfairly treating everyone in a cookie cutter sort of way and not taking into account the age at which it occurs. That makes such a huge difference and requires a different way to deal with it.
I believe Kintor Pharmaceuticals will be the first to make significant changes in system. We're already seeing it with the speed at which Pyrilutamide is flying through the clinical trials at unprecedented speeds.
I'm definitely not Chinese but I do respect the way China does certain things. Their very serious work ethic and ability to not be influenced by external standards and corruption is definitely one of a kind and I believe it will be the reason we get better treatment than we currently have first coming out from Kintor.
Pyrilutamide and GT20029 are the ones im really interested in from Kintor Pharmaceuticals. Pyrilutamide is already is soon to be in Phase 3 in China and GT20029 has already started a Phase 1.
If all goes well we should be Pyrilutamide around 2023 or at best around late 2022.
What I find interesting is that they claim to not have the side effects of Propecia as they are using another method to deal with DHT that doesn't prevent DHT production but rather deal with the AR sensitivity to DHT by creating an AR Receptor Antagonist with Pyrilutamide and an AR degrador with GT20029.
Since DHT is important and we've seen inhibiting the production of DHT causes a ripple effect of health problems, I find the alternative solutions by Kintor and Pyrilutamide very interesting.